The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Darovasertib plus crizotinib vs investigator’s choice as first-line treatment for patients with HLA-A2 negative metastatic uveal melanoma: Primary results from the OptimUM-02 trial.
 
Marlana Orloff
Employment - Pfizer (I)
Honoraria - Immunocore
Consulting or Advisory Role - Delcath Systems; IDEAYA Biosciences; Immunocore; Replimune; TriSalus Life Sciences
Speakers' Bureau - Immunocore
Research Funding - Bristol-Myers Squibb (Inst); Delcath Systems (Inst); IDEAYA Biosciences (Inst); Immunocore (Inst); iOnctura (Inst); Iovance Biotherapeutics (Inst); Linnaeus Therapeutics (Inst); Novelwise (Inst); Regeneron (Inst); Replimune (Inst); TriSalus Life Sciences (Inst)
 
Egle Ramelyte
Stock and Other Ownership Interests - Lilly; Novo Nordisk
Honoraria - BMS GmbH & Co. KG; Galderma; Lilly; MSD; Pierre Fabre; Regeneron; Sanofi
Consulting or Advisory Role - Amgen; Kyowa Kirin International; Pierre Fabre; Sanofi/Regeneron
Speakers' Bureau - BMS GmbH & Co. KG; MSD; Sanofi/Regeneron
Research Funding - Amgen (Inst); Sanofi/Regeneron (Inst); Sun Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Contribution to UpToDate chapter update for Superficial acitic porokeratosis.
Travel, Accommodations, Expenses - Amgen; Pierre Fabre; Sanofi
 
Marcus Butler
Honoraria - Bristol-Myers Squibb; Medison; Merck; Novartis; Pfizer; Roche; Sanofi
Consulting or Advisory Role - Adaptimmune; Adaptimmune; Bristol-Myers Squibb; EMD Serono; Genzyme; GlaxoSmithKline; GlaxoSmithKline; IDEAYA Biosciences; Immunocore; Immunovaccine; Instil Bio; Iovance Biotherapeutics; LaRoche Posay; Medison; Merck; Novartis; Novartis; Pfizer; Regeneron; Sanofi; Sun Pharma
Research Funding - Merck (Inst); Novartis Canada Pharmaceuticals Inc (Inst); Takara Bio (Inst)
Expert Testimony - Merck
 
Piotr Rutkowski
Honoraria - Bristol-Myers Squibb; Genesis Pharma; Medison; Merck; MSD; Novartis; Pierre Fabre
Consulting or Advisory Role - Amgen; AstraZeneca; Blueprint Medicines; Bristol-Myers Squibb; MSD; Novartis; Philogen; Pierre Fabre
Speakers' Bureau - Genesis Pharma; Medison; Pierre Fabre
Research Funding - Bristol-Myers Squibb (Inst); Novartis (Inst); Pierre Fabre (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Orphan Europe; Pierre Fabre
 
Lorenza Di Guardo
No Relationships to Disclose
 
Matteo Carlino
Honoraria - Bristol-Myers Squibb; MSD; Novartis
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Eisai; IDEAYA Biosciences; Innovent Biologics; Medison; Medison; Merck Serono; Moderna Therapeutics; MSD; Nektar; Novartis; OncoSec; Pierre Fabre; QBiotics; Regeneron; Roche; Sanofi; Strand Therapeutics
 
Bartosz Chmielowski
Consulting or Advisory Role - Delcath Systems; Fortvita Biosciences; Immunocore; SERVIER; SpringWorks Therapeutics; Treeline Biosciences; TuHura
Research Funding - Adagene (Inst); Advenchen Laboratories (Inst); Ascentage Pharma (Inst); Bristol-Myers Squibb (Inst); GenVivo (Inst); Georgiamune (Inst); IDEAYA Biosciences (Inst); immatics (Inst); Immunocore (Inst); Kezar Life Sciences (Inst); Kinnate Biopharma (Inst); Krystal Biotech (Inst); Macrogenics (Inst); Nested Therapeutics (Inst); Pierre Fabre (Inst); PTC Therapeutics (Inst); RAPT Therapeutics (Inst); Regeneron (Inst); Replimune (Inst); TriSalus Life Sciences (Inst); Xencor (Inst); Xilio Therapeutics (Inst)
Travel, Accommodations, Expenses - immatics
 
Lucy Kennedy
Research Funding - EpicentRx; IDEAYA Biosciences; Regeneron
 
Kamaneh Montazeri
No Relationships to Disclose
 
Joseph Sacco
Honoraria - Immunocore; Replimune
Consulting or Advisory Role - Delcath Systems (Inst); Immunocore; Immunocore (Inst); Replimune (Inst)
Research Funding - BMS (Inst); IDEAYA Biosciences (Inst); Immunocore (Inst); Replimune (Inst)
 
Ernesto Rossi
Consulting or Advisory Role - Bristol Myers Squibb; Delcath Systems; Immunocore; MSD; Novartis; Pierre Fabre; Servier
Research Funding - IDEAYA Biosciences (Inst); Immunocore (Inst); Regeneron (Inst)
Travel, Accommodations, Expenses - Bayer; Ipsen; Janssen; Pierre Fabre
 
Victoria Atkinson
Honoraria - Bristol-Myers Squibb; Immtech; Immunocore; Merck Sharp & Dohme; Novartis; Pierre Fabre; Primmune Therapeutics; Provectus Biopharmaceuticals; QBiotics
Consulting or Advisory Role - Bristol-Myers Squibb; Immunocore; Merck Serono; Merck Sharp & Dohme; Novartis; QBiotics
Speakers' Bureau - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis
Expert Testimony - Bristol-Myers Squibb/Celgene
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; OncoSec; Pierre Fabre
 
Rizwan Haq
No Relationships to Disclose
 
Meredith McKean
Consulting or Advisory Role - Abbvie (Inst); Bristol-Myers Squibb (Inst); Castle Biosciences (Inst); Daiichi Sankyo (Inst); IDEAYA Biosciences (Inst); IQvia (Inst); Merck (Inst); Moderna Therapeutics (Inst); Pfizer (Inst); Pierre Fabre (Inst); Regeneron (Inst); Revolution Medicines (Inst)
Research Funding - Arcus Biosciences (Inst); Aulos Bioscience (Inst); Bayer (Inst); Bicycle Therapeutics (Inst); BioNTech (Inst); Boehringer Ingelheim (Inst); C4 Therapeutics (Inst); Daiichi Sankyo (Inst); Dragonfly Therapeutics (Inst); Erasca, Inc (Inst); GenVivo (Inst); Gilead Sciences (Inst); IDEAYA Biosciences (Inst); Ikena Oncology (Inst); immatics (Inst); Immunocore (Inst); Iovance Biotherapeutics (Inst); Jazz Pharmaceuticals (Inst); Kezar Life Sciences (Inst); Krystal Biotech (Inst); Merck (Inst); Moderna Therapeutics (Inst); Nested Therapeutics (Inst); Novartis (Inst); NucMito Pharmaceuticals (Inst); OncoC4 (Inst); Pfizer (Inst); Pierre Fabre (Inst); Prelude Therapeutics (Inst); Regeneron (Inst); Repimune (Inst); Sapience Therapeutics (Inst); Synthorx (Inst); Teva (Inst); TScan Therapeutics (Inst)
 
George Cole
Employment - IDEAYA Biosciences
 
Hetal Patel
Employment - IDEAYA Biosciences
 
Long Kwei
Employment - IDEAYA Biosciences
 
Jasgit Sachdev
Employment - Biosplice; IDEAYA Biosciences
Stock and Other Ownership Interests - Biosplice; IDEAYA Biosciences
Travel, Accommodations, Expenses - IDEAYA Biosciences
Other Relationship - IDEAYA Biosciences; IDEAYA Biosciences
 
Darrin Beaupre
Employment - IDEAYA Biosciences
Leadership - IDEAYA Biosciences
Stock and Other Ownership Interests - IDEAYA Biosciences
Research Funding - IDEAYA Biosciences
Patents, Royalties, Other Intellectual Property - Patents associated with Ideaya Biosciences pipeline
Travel, Accommodations, Expenses - IDEAYA Biosciences
 
Sophie Piperno-Neumann
Consulting or Advisory Role - Deciphera; Immunocore; Replimune
Research Funding - Foghorn Therapeutics (Inst); MSD (Inst)
Travel, Accommodations, Expenses - Deciphera; Immunocore; PharmaMar